自願公告 - CU-40102（外用非那雄胺噴霧劑）及CU-30101（局部外用利多卡因丁卡因乳膏劑）中國III期臨床試驗結果在第十九屆CDA年會發佈

1 ׌ ࠿ ዄ΂Оப΂f Cutia Therapeutics 科笛集團 ʮ̡ ΅˾໮j2487 Іᗴʮѓ CU-40102ԟඪᶶᄝᗯኒ ʿ CU-30101€҅௅̮͜лἑΪɕ̔ΪԪၷኒ ʕ਷III֣CDA ϋึ೯б ୊ණྠ € ˜͉ʮ̡᙮ʮ̡୕၈ ˜͉ණྠٝ f ͉ʮ̡໨ԫึ € ˜໨ԫึۜCU-40102€̮ ٙCU-30101€҅௅̮͜лἑΪɕ̔Ϊ ʕ਷IIIϋึ࿬Ό ኪɽึ € ˜CDAϋึஹᚃ ɝ፯ CDA˥๟f CU-40102ʕ਷III؈ CU-40102ٙIIIeτᅌኒ࿁๫ ༊᜕d˸൙П CU-40102f༈ ᑗґ༊᜕΍ɝଡ଼ 270ୋ 24ٙ ආ Бə൙Пf 2 ᐕ 24dCU-40102 ଡ଼ա༊ ׵ ኪจ່ (P<0.05)ࠅ ੽ୋ 12௟௅ˣቻ൙ ଟd24ܝCU-40102ኪ จ່ (P<0.05)dCU-40102Ԅλd CU-40102 ଡ଼ၾτᅌኒଡ଼ʔԄԫ΁ (AE)ʔԄԫ΁ (SAE)ʔԄԫ΁ (TEAE)f CU-40102อᖹɪ̹͡ሗ € ˜NDA׵2024 ϋ1္ຖ၍ଣ҅ €˜ᖹ္҅׵2024 ϋ4ሊ͛໇౤ʹ NDA f މ2024 ϋ1˜31˚ʿ2024 ϋ4˜30˚ʘІᗴʮѓf CU-30101ʕ਷IIIᑗґ༊᜕ഐ ؈ CU-30101ٙIIIᖹ࿁ ᑗґ༊᜕d˸൙П CU-30101׌ f༈ᑗґ༊᜕΍ɝଡ଼ 286d˸ਞˢႡኒ Pliaglis ®лἑΪɕ̔ΪԪ ၷ €˜Pliaglis ®уՍ़೨ൖᙂᅼᏝ൙ʱ €˜VASආБə൙Пf ௅ VAS€CU-30101 ਉ-Pliaglis ® ਜගᇍఖʫdᜑͪ CU-30101 ၾPliaglis ®຅d༺Ց ମe ࿁Շ၇ ኪจ່(P >0.05)d CU-30101ʔԄԫ΁೯͛fCU-30101 ਉၾ Pliaglis ®d˲ၾ Pliaglis ®तᅄɓ ໮f CU-30101׵2024 ϋ7ᖹ္҅աଣf༉ઋሗਞቡ މ2024 ϋ7˜31 ˚ʘІᗴʮѓf 3 ᙆѓj͉ʮ̡ਗ਼ঐ௰୞ϓ̌ቖਯ CU-40102 ʿCU-30101f͉ʮ̡ ਕሗᄲฐБԫf ໨ԫึն Cutia Therapeutics 科笛集團 ੂБ໨ԫ ੵᆀᆀ ಥd2024 ϋ11 ˜28 ˚ ܼi)΋͛i(ii)ੂБ໨ԫ ௹ɻeᑽӎ௹ɻeරᖋ௹ɻʿเථᒳɾɻiʿ (iii)؏׼ ΋͛eௗᅃʠ΋͛ʿ໢ወജ΋͛f

The release as fetched from its publisher. cutiatx.com ↗